Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Neurosurg ; 126(1): 184-190, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27058197

RESUMO

OBJECTIVE Application for a residency position in neurosurgery is a highly competitive process. Visiting subinternships and interviews are integral parts of the application process that provide applicants and programs with important information, often influencing rank list decisions. However, the process is an expensive one that places significant financial burden on applicants. In this study, the authors aimed to quantify expenses incurred by 1st-year neurosurgery residents who matched into a neurosurgery residency program in 2014 and uncover potential trends in expenses. METHODS A 10-question survey was distributed in partnership with the Society of Neurological Surgeons to all 1st-year neurosurgery residents in the United States. The survey asked respondents about the number of subinternships, interviews, and second looks (after the interview) attended and the resultant costs, the type of program match, preferences for subinternship interviews, and suggestions for changes they would like to see in the application process. In addition to compiling overall results, also examined were the data for differences in cost when stratifying for region of the medical school or whether the respondent had contact with the program they matched to prior to the interview process (matched to home or subinternship program). RESULTS The survey had a 64.4% response rate. The mean total expenses for all components of the application process were US $10,255, with interview costs comprising the majority of the expenses (69.0%). No difference in number of subinternships, interviews, or second looks attended, or their individual and total costs, was seen for applicants from different regions of the United States. Respondents who matched to their home or subinternship program attended fewer interviews than respondents who had no prior contact with their matched program (13.5 vs 16.4, respectively, p = 0.0023) but incurred the same overall costs (mean $9774 vs $10,566; p = 0.58). CONCLUSIONS Securing a residency position in neurosurgery is a costly process for applicants. No differences are seen when stratifying by region of medical school attended or contact with a program prior to interviewing. Interview costs comprise the majority of expenses for applicants, and changes to the application process are needed to control costs incurred by applicants.


Assuntos
Internato e Residência/economia , Neurocirurgiões/economia , Neurocirurgiões/educação , Neurocirurgia/economia , Neurocirurgia/educação , Custos e Análise de Custo , Humanos , Faculdades de Medicina , Sociedades Médicas , Estados Unidos
2.
Am J Manag Care ; 20(3): e90-7, 2014 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-24773330

RESUMO

OBJECTIVES: A "chiral switch" occurs in the pharmaceutical market when a drug made up of 2 enantiomer forms is replaced with a purified single-enantiomer version, often in the context of a patent expiration. We studied the prevalence of chiral switching in the United States over the past decade, including trends in use of, and expenditures on, these products in Medicaid. STUDY DESIGN: Retrospective analysis. METHODS: We used US Adopted Names prefixes (lev/levo/ar/es/dex/dextro) to identify all single-enantiomer drugs approved from 2001 to 2011. From publicly available US Food and Drug Administration (FDA) approval documents, we extracted the characteristics of the pivotal premarket trials for the single enantiomers. Specifically, we evaluated whether the single enantiomer was directly compared with the precursor racemic drug and whether there was evidence of superior efficacy. We used quarterly drug expenditure data from each state Medicaid program to chart trends in use of, and spending on, the single-enantiomer products and their racemic precursors during the study period. RESULTS: From 2001 to 2011, the FDA approved 9 single-enantiomer products: dexlansoprazole, levoleucovorin, levocetirizine, armodafinil, arformoterol, eszopiclone, escitalopram, dexmethylphenidate, and esomeprazole. Of those 9 drugs, 3 had at least 1 pre-approval randomized trial that included the racemic precursor as a direct comparator, but there was no evidence of superiority of the single enantiomer over the racemic at comparable doses. Between 2001 and 2011, US Medicaid programs spent approximately $6.3 billion on these 9 single-enantiomer drugs. CONCLUSIONS: Recently approved single-enantiomer drugs showed no evidence of superior efficacy over the older racemic precursors in the pivotal trials leading to their approval, and in a majority of cases, they were not directly compared.


Assuntos
Aprovação de Drogas , Prescrições de Medicamentos/estatística & dados numéricos , Medicaid/economia , Antídotos/química , Antídotos/economia , Compostos Azabicíclicos/química , Compostos Azabicíclicos/economia , Compostos Benzidrílicos/química , Compostos Benzidrílicos/economia , Broncodilatadores/química , Broncodilatadores/economia , Estimulantes do Sistema Nervoso Central/química , Estimulantes do Sistema Nervoso Central/economia , Cetirizina/química , Cetirizina/economia , Dexlansoprazol/química , Dexlansoprazol/economia , Cloridrato de Dexmetilfenidato/química , Cloridrato de Dexmetilfenidato/economia , Medicamentos Genéricos/economia , Esomeprazol/química , Esomeprazol/economia , Zopiclona , Etanolaminas/química , Etanolaminas/economia , Fumarato de Formoterol , Antagonistas não Sedativos dos Receptores H1 da Histamina/química , Antagonistas não Sedativos dos Receptores H1 da Histamina/economia , Humanos , Hipnóticos e Sedativos/química , Hipnóticos e Sedativos/economia , Levoleucovorina/química , Levoleucovorina/economia , Modafinila , Patentes como Assunto , Piperazinas/química , Piperazinas/economia , Inibidores da Bomba de Prótons/química , Inibidores da Bomba de Prótons/economia , Estudos Retrospectivos , Estereoisomerismo , Estados Unidos , United States Food and Drug Administration , Promotores da Vigília/química , Promotores da Vigília/economia
3.
J Gen Intern Med ; 28(6): 787-92, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23225257

RESUMO

BACKGROUND: Despite a growing need for primary care physicians in the United States, the proportion of medical school graduates pursuing primary care careers has declined over the past decade. OBJECTIVE: To assess the association of medical school research funding with graduates matching in family medicine residencies and practicing primary care. DESIGN: Observational study of United States medical schools. PARTICIPANTS: One hundred twenty-one allopathic medical schools. MAIN MEASURES: The primary outcomes included the proportion of each school's graduates from 1999 to 2001 who were primary care physicians in 2008, and the proportion of each school's graduates who entered family medicine residencies during 2007 through 2009. The 25 medical schools with the highest levels of research funding from the National Institutes of Health in 2010 were designated as "research-intensive." KEY RESULTS: Among research-intensive medical schools, the 16 private medical schools produced significantly fewer practicing primary care physicians (median 24.1% vs. 33.4%, p < 0.001) and fewer recent graduates matching in family medicine residencies (median 2.4% vs. 6.2%, p < 0.001) than the other 30 private schools. In contrast, the nine research-intensive public medical schools produced comparable proportions of graduates pursuing primary care careers (median 36.1% vs. 36.3%, p = 0.87) and matching in family medicine residencies (median 7.4% vs. 10.0%, p = 0.37) relative to the other 66 public medical schools. CONCLUSIONS: To meet the health care needs of the US population, research-intensive private medical schools should play a more active role in promoting primary care careers for their students and graduates.


Assuntos
Escolha da Profissão , Médicos de Atenção Primária/provisão & distribuição , Atenção Primária à Saúde , Faculdades de Medicina/economia , Pesquisa Biomédica/economia , Pesquisa Biomédica/estatística & dados numéricos , Medicina de Família e Comunidade , Humanos , Internato e Residência/estatística & dados numéricos , Médicos de Atenção Primária/educação , Médicos de Atenção Primária/estatística & dados numéricos , Setor Privado/economia , Setor Privado/estatística & dados numéricos , Setor Público/economia , Setor Público/estatística & dados numéricos , Apoio à Pesquisa como Assunto/estatística & dados numéricos , Faculdades de Medicina/estatística & dados numéricos , Estados Unidos , Recursos Humanos
4.
J Chem Phys ; 121(21): 10674-9, 2004 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-15549952

RESUMO

For a model system of polyethylene of chain lengths 40 and 100 carbon atoms, we calculated the pressure at different densities and compared them with the experimental values. The simulation was conducted on the second nearest neighbor diamond lattice, and the pressure was calculated using the virtual-volume-variation method after the system was reverse mapped to its fully atomistic form in continuous space and energy minimized. In addition, the pressure was also calculated from the virial route by conducting a short molecular dynamics simulation starting from the energy minimized structure. We show that the pressure obtained from our simulations is quite reasonable in the length of simulation time (in Monte Carlo steps) normally employed in our group. These results provide additional evidence for the equilibration of our model systems, and methodology to calculate the pressure in our lattice models.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA